skip to Main Content
  • This page as PDF
September 16, 2020 12:00 - 1:00 PM ET

Market Access Enablement Strategies, Part 1: Launching in a Virtual World

Summary

Join Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.

From value, evidence, and pricing to access, coverage, and reimbursement to insights and commercialization strategy, the COVID-19 pandemic has created new challenges for innovative life sciences companies to bring products to market. Join our experts to learn about the approaches that can be taken in this virtual era to support stakeholder engagement and patient uptake.

Key Topics

  • Pre-/post-launch planning
  • Third-party channel and distribution
  • Patient access strategy
  • Customer models and engagement

Don’t forget to register for Part 2 of our Market Access webinar series.

Panelists

Moderator
Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Speaker
Lance Grady , Practice Director, Commercialization & Regulatory Strategy

As the leader of the Market Access Practice, Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

Speaker
Omar Hafez , Managing Director, Commercialization & Regulatory Strategy

Omar advises a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning.

Speaker
Dana Macher , Managing Director, Commercialization & Regulatory Strategy

Dana Macher specializes in market access and commercialization.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top